subgroup
of
drug)
→
ReceivesAction
→
used by cancer patients
Typicality: | 0.677 |
Saliency: | 1.000 |
into a standardized treatment regimen | 3 | other |
antineoplastic drug → be used by → cancer patients | 4 |
antineoplastic drug → be used to treat → cancer | 4 |
negative | neutral | positive |
0.206 | 0.748 | 0.045 |
Raw frequency | 8 |
Normalized frequency | 1.000 |
Modifier score | 0.500 |
Perplexity | 60.529 |